Scarica l'app Stockscreener
87.30
0.76%
-0.67
Dopo l'orario di chiusura:
87.25
-0.05
-0.06%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$87.97
Aprire:
$88.2
Volume 24 ore:
1.15M
Relative Volume:
0.96
Capitalizzazione di mercato:
$9.73B
Reddito:
$13.38B
Utile/perdita netta:
$418.00M
Rapporto P/E:
26.37
EPS:
3.3112
Flusso di cassa netto:
$391.00M
1 W Prestazione:
-3.92%
1M Prestazione:
-0.89%
6M Prestazione:
+14.43%
1 anno Prestazione:
+29.51%
Intervallo 1D:
$87.11
$88.22
Intervallo di 1 settimana:
$87.11
$90.54
Portata 52W:
$61.95
$92.18
Henry Schein Inc Stock (HSIC) Company Profile
Nome
Henry Schein Inc
Settore
Industria
Telefono
(631) 843-5500
Indirizzo
135 DURYEA RD, MELVILLE, NY
Compare HSIC vs MCK, COR, CAH, AHG
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
HSIC
Henry Schein Inc
|
87.30 | 9.80B | 13.38B | 418.00M | 391.00M | 3.3112 |
MCK
Mckesson Corp
|
880.86 | 103.96B | 403.43B | 5.10B | 5.41B | 38.47 |
COR
Cencora Inc
|
320.95 | 61.70B | 328.68B | 2.55B | 1.56B | 13.03 |
CAH
Cardinal Health Inc
|
236.02 | 55.82B | 250.74B | 1.55B | 4.39B | 6.5398 |
AHG
Akso Health Group Adr
|
0.7302 | 685.45M | 14.85M | -136.07M | 7.25M | -0.4726 |
Henry Schein Inc Stock (HSIC) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-04-16 | Iniziato | BTIG Research | Neutral |
| 2026-04-15 | Iniziato | Citigroup | Buy |
| 2026-02-23 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2025-12-09 | Iniziato | Barclays | Overweight |
| 2025-08-26 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2025-07-25 | Downgrade | Stifel | Buy → Hold |
| 2025-07-14 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2025-02-14 | Iniziato | Wells Fargo | Equal Weight |
| 2025-01-06 | Aggiornamento | BofA Securities | Underperform → Buy |
| 2024-12-04 | Iniziato | Mizuho | Neutral |
| 2024-07-22 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2024-02-26 | Iniziato | Leerink Partners | Market Perform |
| 2023-12-12 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2023-11-10 | Aggiornamento | Stifel | Hold → Buy |
| 2022-08-08 | Aggiornamento | UBS | Sell → Neutral |
| 2022-07-21 | Downgrade | Goldman | Buy → Neutral |
| 2022-06-14 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2022-05-13 | Ripresa | Credit Suisse | Outperform |
| 2022-01-31 | Iniziato | Morgan Stanley | Underweight |
| 2022-01-07 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2021-10-01 | Ripresa | Credit Suisse | Neutral |
| 2021-02-08 | Ripresa | Piper Sandler | Overweight |
| 2021-01-04 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2020-11-03 | Aggiornamento | Barrington Research | Mkt Perform → Outperform |
| 2020-05-06 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| 2020-04-07 | Aggiornamento | Goldman | Neutral → Buy |
| 2020-04-02 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2020-01-09 | Downgrade | BofA/Merrill | Neutral → Underperform |
| 2020-01-02 | Aggiornamento | Evercore ISI | Underperform → In-line |
| 2019-08-07 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2019-05-30 | Iniziato | Wolfe Research | Underperform |
| 2019-05-15 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| 2019-04-18 | Iniziato | Guggenheim | Buy |
| 2019-01-17 | Iniziato | UBS | Sell |
| 2019-01-03 | Downgrade | Evercore ISI | In-line → Underperform |
| 2019-01-02 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2018-11-08 | Reiterato | Barrington Research | Outperform |
| 2018-10-25 | Downgrade | Edward Jones | Hold → Sell |
| 2018-10-19 | Ripresa | Goldman | Neutral |
| 2018-10-04 | Reiterato | Robert W. Baird | Outperform |
| 2018-08-07 | Reiterato | Stifel | Hold |
| 2018-04-24 | Downgrade | Goldman | Buy → Neutral |
| 2018-04-04 | Aggiornamento | Leerink Partners | Mkt Perform → Outperform |
Mostra tutto
Henry Schein Inc Borsa (HSIC) Ultime notizie
Henry Schein Executive Andrea Albertini Reports Two Stock Disposals on September 8, 2026 - Kalkine Media
Tax withholding prompts Henry Schein (HSIC) insider to return shares - Stock Titan
Henry Schein stock holds steady after recent earnings update - ad-hoc-news.de
Precision Trading with Henry Schein Inc. (HSIC) Risk Zones - Stock Traders Daily
Henry Schein stock rises on a new distribution deal - ad-hoc-news.de
Henry Schein to Present at Baird Global Healthcare Conference - dentistrytoday.com
Henry Schein to Distribute Applied BioCode's MDx-3000 System in US - marketscreener.com
Applied BioCode Announces Distribution Agreement with Henry Schein - Yahoo Finance
Henry Schein to Participate in Upcoming Investor Conference in September - Business Wire
How Investors May Respond To Henry Schein (HSIC) Distributing DermaSensor’s Skin Cancer Detection Device - webull.com
Henry Schein stock gains after strong Q2 2026 results and raised outlook - ad-hoc-news.de
Henry Schein, Inc. (HSIC) Stock Analysis: Unveiling a 9.33% Upside Opportunity in the Medical Distribution Sector - DirectorsTalk Interviews
Henry Schein stock gains institutional support as new diagnostic partnership advances strategy - AD HOC NEWS
Henry Schein Inc. stock outperforms competitors despite losses on the day - MarketWatch
Henry Schein Inc. helps children start the school year - Reading Eagle
Henry Schein stock rises after Q2 earnings beat - AD HOC NEWS
Henry Schein (HSIC) is an Incredible Growth Stock: 3 Reasons Why - Yahoo Finance
Why Is Henry Schein (HSIC) Up 0.9% Since Last Earnings Report? - Yahoo Finance
Henry Schein shares technical analysis: Resistance test at $92.68 in focus - Traders Union
Why Henry Schein (HSIC) is a Top Growth Stock for the Long-Term - Eastern Progress
Is Henry Schein (HSIC) Stock Undervalued Right Now? - Yahoo Finance
Henry Schein (HSIC) Looks Modestly Undervalued, Is More Upside Still Available? - Yahoo Finance
Growth Trajectory and Attractive Valuations Support Henry Schein’s (HSIC) Bullish Thesis - Yahoo Finance
Henry Schein, Inc. (HSIC) Stock Analysis: Exploring a 9.68% Upside Potential in the Medical Distribution Sector - DirectorsTalk Interviews
Henry Schein, Inc. (HSIC) Stock Report: Analyst Consensus Points to 10.95% Potential Upside - DirectorsTalk Interviews
Henry Schein Inc. stock outperforms competitors on strong trading day - MarketWatch
Henry Schein (HSIC) Q1 2026 Earnings Call Transcript - fortune.com
Henry Schein stock holds steady as 2026 outlook is raised and Q2 earnings beat - Ad-hoc-news.de
What Are Wall Street Analysts' Target Price for Henry Schein Stock? - Yahoo Finance
Is HSIC Worth Buying as Growth Improves but Execution Risks Persist? - TradingView
Henry Schein, Special Olympics re-up partnership - HME News
Henry Schein (NASDAQ:HSIC) Stock Price Expected to Rise, BTIG Research Analyst Says - MarketBeat
Tranche Update on Henry Schein, Inc.'s Equity Buyback Plan announced on December 13, 2018. - marketscreener.com
BTIG Adjusts Price Target on Henry Schein to $110 From $100, Maintains Buy Rating - marketscreener.com
Henry Schein and Special Olympics Renew Partnership Through 2030 - Orthodontic Products
Henry Schein stock holds steady as higher-margin Q2 2026 lifts guidance - AD HOC NEWS
Building a healthier future together: Henry Schein and Special Olympics renew partnership through 2030 - Special Olympics
HSIC Raises 2026 Outlook as Sales and Margin Momentum Accelerates - TradingView
Empowered Funds LLC Has $851,000 Position in Henry Schein, Inc. $HSIC - MarketBeat
Buckland Partners Management Co LLC Makes New Investment in Henry Schein, Inc. $HSIC - MarketBeat
Henry Schein stock holds near a 52-week high after a Buy upgrade - Ad-hoc-news.de
Henry Schein, Inc. (HSIC) Stock Analysis: Exploring Growth Potential Amidst a 8.68% Upside - DirectorsTalk Interviews
Henry Schein (NASDAQ:HSIC) Rating Increased to Buy at Wall Street Zen - MarketBeat
How Henry Schein’s Strong Q2 Earnings and Higher 2026 Sales Outlook Will Impact Henry Schein (HSIC) Investors - simplywall.st
Form 144 | Henry Schein(HSIC.US) Insider Proposes to Sell 3.18 Million in Common Stocks - Moomoo
Henry Schein (HSIC) insider Bergman plans $3.18M sale under Form 144 - Stock Titan
HSIC|Henry Schein Inc|Price:90.000|Chg%:+0.230 - tradingkey.com
5 Insightful Analyst Questions From Henry Schein’s Q2 Earnings Call - Yahoo Finance
Henry Schein, Inc. (HSIC) Stock Forecasts - Yahoo Finance
Why Henry Schein's (NASDAQ:HSIC) Earnings Are Better Than They Seem - Moomoo
Henry Schein's (NASDAQ:HSIC) Earnings Seem To Be Promising - simplywall.st
Henry Schein Inc Azioni (HSIC) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
8.74%
0.93%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):